Health & Biotech
Health & Biotech
ASX Health Stocks: The TGA rejects MMDA and magic mushrooms, deals blow to ASX psychedelic players
Health & Biotech
This ASX biotech is one of the few running a Phase 3 clinical trial against COVID-19, and it’s firmly on track to proceed
Health & Biotech
IDT falls 40pc after Morrison government rejection; what now for the company’s COVID vaccine manufacturing ambitions?
Health & Biotech
ASX Health Stocks: CSL drags Healthcare index down 5pc on a mammoth $6.3bn cap raise
Health & Biotech
PharmAust’s subsidiary Epichem strikes $1m extension deal with world renowned organisation DNDi
Health & Biotech
Wellnex shares rise on Pharmacy Own launch under CH2 deal
Health & Biotech
ASX Health Stocks: Virtus is being pursued as Bionomics prepares for dual Nasdaq listing
Health & Biotech
With Boots on ground in UK, organic cannabis innovator Dragonfly has blue sky options ahead of ASX debut
Health & Biotech
With four clinical trials kicking off, PharmAust is set for a busy 2022
Health & Biotech
Osteopore’s new Singapore deal takes a big bite out of next-gen dental implant tech
Health & Biotech
What you’ve been vaping for: MGC Pharma now has the first-ever Cannabinoid vape available as an unapproved therapeutic good for use in Australia
Health & Biotech
Singular Health officially enters the Mediverse
Health & Biotech
EZZ launches new products to support digestive health
Health & Biotech
ASX Health Stocks: Arovella and Imugene break away from the pack on major announcements
Health & Biotech
Dr Boreham’s Crucible: Visoneering’s taking the longview on short-sightedness – and it’s starting to pay off
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.